Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors

Authors

  • Sophie Roca Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital-CHU Bordeaux, France
  • Amandine Quivy Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital-CHU Bordeaux, France
  • Marine Gross-Goupil Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital-CHU Bordeaux, France
  • Jean-Christophe Bernhard Department of Urology, Hôpital Pellegrin, Bordeaux University Hospital-CHU Bordeaux, France
  • Henri De Clermont Department of Nuclear Medecine, Hôpital Pellegrin, Bordeaux University Hospital-CHU Bordeaux, France
  • Alain Ravaud Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital-CHU Bordeaux, France;University of Bordeaux 2 (Victor Segalen), Bordeaux, France; Clinical Investigational Center (CIC), INSERM 005, Bordeaux, France

DOI:

https://doi.org/10.3109/0284186X.2011.592149

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-10-01

How to Cite

Roca, S., Quivy, A., Gross-Goupil, M., Bernhard, J.-C., De Clermont, H., & Ravaud, A. (2011). Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors. Acta Oncologica, 50(7), 1135–1136. https://doi.org/10.3109/0284186X.2011.592149

Issue

Vol. 50 No. 7 (2011): Acta Oncologica

Section

Articles